Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

P27 anticorps

Reactivité: Humain, Rat IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7249468
  • Antigène
    P27
    Reactivité
    • 31
    • 16
    • 15
    • 4
    • 1
    • 1
    Humain, Rat
    Hôte
    • 24
    • 8
    Lapin
    Clonalité
    • 24
    • 8
    Polyclonal
    Conjugué
    • 20
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Inconjugué
    Application
    • 17
    • 15
    • 9
    • 5
    • 4
    • 4
    • 4
    Immunohistochemistry (IHC)
    Attributs du produit
    Polyclonal Antibody
    Purification
    Affinity purification
    Immunogène
    KLH conjugated Synthetic peptide corresponding to Mouse P27 KIP1
    Isotype
    IgG
  • Indications d'application
    IHC 1:100-1:400
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.89 mg/mL
    Buffer
    PBS with 0.02 % sodium azide, 1 % BSA and 50 % glycerol, pH 7.4
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    P27
    Synonymes
    anticorps Kip1, anticorps p27, anticorps cyclin dependent kinase inhibitor 1B, anticorps CDKN1B
    Classe de substances
    Viral Protein
    Sujet
    This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).
    UniProt
    P46527, P46414
Vous êtes ici:
Support technique